Head-to-head · WeighScore
GOAL.MD vs TD Tele-Doc Weight Loss
The verdict
GOAL.MD takes it — 68.4/100 to 61.8/100.
GOAL.MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | GOAL.MD | TD Tele-Doc Weight Loss |
|---|---|---|
| WeighScore | 68.4/100 | 61.8/100 |
| Grade | C | C |
| Scorecard rank | #151 | #288 |
| Semaglutide | $179/mo | Not disclosed |
| Tirzepatide | $249/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | 2 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #151 · C
Strengths
- Transparent dose-tiered pricing on brand pens
- LegitScript Certified
- Manual-renewal model — no surprise auto-billing
- Free nutrition coach included
- BBB A+ rating since 2021
Where it loses points
- No named compounding pharmacy partner
- Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
- No URAC or PCAB pharmacy accreditation
Graded #288 · C
Strengths
- Brand Wegovy/Zepbound AND compounded sema available; prescribing based on medical history and coverage
- 100% virtual — weekly appointments with board-certified MDs from home; no travel required
- Remote Patient Monitoring Starter Box: biometric scale + blood pressure cuff sync to care team in real time
- In-network with most commercial insurance plans; may cover visits and monitoring equipment
- Physician-led by Dr. Peter Wilbanks MD (30-yr OB/GYN, VCU) and Dr. Michael Perini MD (ABIM board-certified)
Where it loses points
- No public cash pricing; cost entirely depends on insurance coverage — not viable for uninsured patients
- Telehealth available only in Virginia and Maryland; no national reach confirmed
- No Medicare or Medicaid accepted; limited to commercial insurance plans only
- No LegitScript certification found; compounded availability and specific pricing undisclosed on site
- Tirzepatide (Zepbound/Mounjaro) availability less prominent in MD pages; semaglutide is primary focus
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.